Halozyme Therapeutics, Inc. Fourth Quarter and FY 2023 Financial & Operating Results NASDAQ: HALO February 20, 2024 Forward Looking Statements In addition to historical information, the statements set forth in this presentation include unexpected levels of revenues (including royalty and milestone revenue received from our forward-looking statements including, without limitation, statements concerning the collaboration partners and product sales), expenditures and costs, unexpected delays in Company’s expec ...